| Bioactivity | Genevant CL1 monohydrochloride is an ionizable lipid (lipid 10, pKa=6.3), and it can be used for mRNA lipid nanoparticle (LNP) vaccine delivery[1][2]. |
| Name | Genevant CL1 monohydrochloride |
| Formula | C39H74ClNO2 |
| Molar Mass | 624.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lam K, Leung A, Martin A, et al. Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine Applications. Adv Mater. 2023;35(15):e2209624. [2]. Michael D Buschmann, et al. Nanomaterial Delivery Systems for mRNA Vaccines. Vaccines (Basel). 2021 Jan 19;9(1):65. |
Genevant CL1 monohydrochloride
CAS: F: C39H74ClNO2 W: 624.46
Genevant CL1 monohydrochloride is an ionizable lipid (lipid 10, pKa=6.3), and it can be used for mRNA lipid nanoparticle
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.